Female CEOs’ ‘Outstanding performance’ in management, marketing and R&D at listed pharmas

Although the female executive ratio is only 7% in listed pharmaceutical companies, they are evaluated to have outstanding performance with their active activities.

According to the Yakup Shinmoon’s(www.yakup.com) analysis result of the listed pharmaceutical companies’ executive status on March 2017, the total 60 female executives reportedly were active for business activities as a female execu...